![Carl Feldbaum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carl Feldbaum
Director/Board Member at
Bio Ventures for Global Health
Profile
Carl B. Feldbaum was the founder of Palomar Corp.
(founded in 1993) and held the title of President from 1993 to 2005.
He is currently the Chairman of Bio Ventures for Global Health (since 2004) and the President of Biotechnology Innovation Organization (since 1993).
In his former positions, he served as Chairman of The Life Sciences Foundation, Director of Connetics Corp.
(2005-2006), Independent Director of Exelixis, Inc. (2007-2023), Non-Executive Director of Actelion Ltd. (2005-2015), Director of Cardiff Oncology, Inc. (2014-2015), and Director of The Biotechnology Institute.
Mr. Feldbaum received his undergraduate degree from Princeton University and his graduate degree from The University of Pennsylvania Law School.
Carl Feldbaum active positions
| Companies | Position | Start |
|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Corporate Officer/Principal | 2004-12-31 |
Bio Ventures for Global Health
 Bio Ventures for Global Health Bio Ventures for Global Health is an organization focused on leveraging biotechnology to address global health challenges. The non-profit company is based in Washington, DC. It collaborates with various stakeholders to develop innovative solutions for diseases that disproportionately affect low-resource settings. Through strategic partnerships and initiatives, the company aims to improve health outcomes and access to healthcare in underserved communities worldwide. The CEO of the company is James C. Greenwood. | Director/Board Member | 2013-06-23 |
Former positions of Carl Feldbaum
| Companies | Position | End |
|---|---|---|
| EXELIXIS, INC. | Director/Board Member | 2023-05-30 |
| CARDIFF ONCOLOGY, INC. | Director/Board Member | 2015-11-12 |
| ACTELION | Director/Board Member | 2015-05-07 |
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Director/Board Member | 2006-12-28 |
Palomar Corp. | Founder | 2004-12-31 |
Training of Carl Feldbaum
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
75
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Connetics Corp.
Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Actelion Ltd.
 Actelion Ltd. Pharmaceuticals: MajorHealth Technology Develops, produces and markets pharmaceutical drugs | Health Technology |
Cardiff Oncology, Inc.
 Cardiff Oncology, Inc. Medical SpecialtiesHealth Technology Develops diagnostic products | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bio Ventures for Global Health
Bio Ventures for Global Health Bio Ventures for Global Health is an organization focused on leveraging biotechnology to address global health challenges. The non-profit company is based in Washington, DC. It collaborates with various stakeholders to develop innovative solutions for diseases that disproportionately affect low-resource settings. Through strategic partnerships and initiatives, the company aims to improve health outcomes and access to healthcare in underserved communities worldwide. The CEO of the company is James C. Greenwood. | |
The Biotechnology Institute
 The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services Focuses on biotechnological research | Commercial Services |
Palomar Corp. | |
The University of Pennsylvania Law School
 The University of Pennsylvania Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Life Sciences Foundation
 The Life Sciences Foundation Miscellaneous Commercial ServicesCommercial Services Engages in education and biotechnology information dissemination | Commercial Services |
- Stock Market
- Insiders
- Carl Feldbaum
